siRNA targeting Livin decreases tumor in a xenograft model for colon cancer

doi:10.3748/wjg.v17.i20.2563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5500)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

446

HTML

4782

Figures (1-8)

272

Sum=5500

May 28, 2011 (publication date) through Nov 15, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. May 28, 2011; 17(20): 2563-2571
Published online May 28, 2011. doi: 10.3748/wjg.v17.i20.2563

Full Size Figure Download Figure

Figure 4 MTT assay after small interfering RNA transfection in HCT116 cell line. A: The proliferation of cells transfected with siRNA was remarkably inhibited at 18 h post-transfection (P = 0.04); B and C: Cellular proliferation at 24 and 30 h post-transfection. The inhibitory effect shown A disappeared, cellular proliferation was similar with control.

Citation: Oh BY, Lee RA, Kim KH. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer. World J Gastroenterol 2011; 17(20): 2563-2571
URL: https://www.wjgnet.com/1007-9327/full/v17/i20/2563.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i20.2563